2027 FDA Licensing Public Health 
SQA
FEBRUARY 15, 2023
Of interest is a reference to the FDA’s draft document “Computer Software Assurance for Production and Quality System Software,” which was recently published on 13 September 2022. A concerted and collaborative effort is essential to address this threat to global health, economies, and security effectively.
SQA
MAY 24, 2023
The deadline for reporting serious incidents not constituting serious public health threats, deaths, or unanticipated serious deteriorations in state of health was reduced to 15 calendar days. Following adoption by the European Council, the formal process of publication in the OJEU may begin, and typically takes up to 30 days.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hall Render
OCTOBER 27, 2023
leads in life expectancy Utah nonprofit pharmaceutical company is fixing the market, producing 80 drugs VERMONT Vermont hospital training staff to be nurses Mental health urgent care takes root in Vermont The state’s health care regulator looks for input in ‘hospital transformation’ process Vt.
Healthcare Law Blog
AUGUST 25, 2022
After 2026, the timing for publication is standardized – the February 1 st two years prior to the price applicability date will be the drug publication date. Fifteen more Part D drugs are set to be published in 2027, followed by 15 Part D and Part B drugs, collectively, in 2028. Negotiation-Eligible Drugs.
Hall Render
NOVEMBER 17, 2023
to expand behavioral health services Michigan teaching hospital to bring in consultants amid debt covenant breach Trinity Health to grow West Michigan orthopedic practice after settling federal lawsuit Healthcare giant McLaren reveals data on 2.2 Supreme Court won’t hear COVID vaccine case filed by N.J.
Expert insights. Personalized for you.
40 
Let's personalize your content